Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stage-related transcriptional changes in HR-positive/HER2-negative breast cancer.

NPJ breast cancer·2026
Same author

Clinician Perspectives on Implementing Breast Cancer-Related Lymphedema Prospective Screening.

JAMA network open·2026
Same author

Comprehensive Clinicopathologic Evaluations of 149 Metaplastic Carcinomas of the Breast Treated With Neoadjuvant and Adjuvant Chemotherapy.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same author

Tumor genomics in patients younger than 40 years of age with metastatic breast cancer.

NPJ precision oncology·2026
Same author

ASO Author Reflections: Axillary Management After Neoadjuvant Endocrine Therapy: An Opportunity for Clinical Trials.

Annals of surgical oncology·2025
Same author

Invited Commentary: Surgeon Well-Being and Marital Stability.

Journal of the American College of Surgeons·2025

Related Experiment Video

Updated: May 21, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

Triple-negative breast cancer

Quyen D Chu1, Tari King, Thelma Hurd

  • 1Health Sciences Center, Louisiana State University, Shreveport, LA 71130, USA.

International Journal of Breast Cancer
|June 1, 2012
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Last Updated: May 21, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020